Homocysteine and hypertension

Journal of Association of Physicians of India

Volumn 50, Issue 5, 2002, Pages 29-35

  Yeolekar, M E ^a   Shete, M M ^a  

^a LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND GENERAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

AGE; DIABETES MELLITUS; GENETICS; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; METABOLISM; REVIEW; RISK FACTOR; VASCULAR DISEASE;

AGE FACTORS; DIABETES COMPLICATIONS; DIABETES MELLITUS; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; HYPERTENSION; RISK FACTORS; VASCULAR DISEASES;

EID: 0036562398     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Wilcken DE, Wilcken B. The pathogenesis of coronary artery disease : A possible role for methionine metabolism. J Clin Invest 1976;57:1079-82.
2. Bortolotto LA, Safar ME, Billaud E. Plasma homocysteine, aortic stiffness, and renal function in hypertensive patients. Hypertension 1999;34:837-42.
3. Seshadri N, Robinson K. Homocysteine, B vitamins and coronary artery disease. Med Clin North Am 2000;84:215-37.
4. Mayer EL, Jacobsen OW, Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1996;27:517-27.
5. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European concerted action project. JAMA 1997;277:1775-81.
6. Tucker KL, Selhub J, Wilson PW. Dietary intake pattern relates to plasma folate and homocysteine concentrations in the Framingham Heart Study. J Nutr 1996;126:3025-31.
7. Lussier-Cacan S, Xbignesse M, Piolot A, et al. Plasma total homocysteine in healthy subjects. Sex specific relation with biological traits. Am J Clin Nutr 1996;64:587-93.
8. Nygard O, Refsum H, Ueland PM, et al. Coffee consumption and plasma total homocysteine. The Hordaland homocysteine study. Am J Clin Nutr 1997;65:136-43.
9. Cravo ML, Gloria LM, Selhub J, et al. Hyperhomocysteinaemia in chronic alcoholism. Correlation with folate, vitamin B12, and vitamin Be status. Am J Clin Nutr 1996;63:220-4.
10. Wilcken DE, Gupta VJ. Sulphur containing aminoacids in chronic renal failure with particular reference to homocysteine and cysteine - homocysteine mixed disulphide. Eur J Clin Invest 1979;9:301-7.
11. Bostom AG, Lathrop L. Hyperhomocysteinaemia in end-stage renal disease : Prevalence, etiology and potential relationship to arteriosclerotic outcomes. Kidney Int 1997;52:10-20.
12. Munshi MN, Stone A, Fink L, et al. Hyperhomocysteinaemia following a methionine load in patients with non-insulin dependent diabetes mellitus and macrovascular disease. Metabolism 1996;45:133-5.
13. Roubenoff R, Dellaripa P, Nadeau MR, et al. Abnormal homocysteine metabolism in rheumatoid arthritis. Arthritis Rheum 1997;40:718-22.
14. Metz J, Bell AH, Flicker L, et al. The significance of subnormal serum vitamin B12 concentration in older people. A case control study. J Am Geriatr Soc 1996;44:1355-61.
15. Hopkins P, Wu L, Wu J, et al. Higher plasma homocysteine and increased susceptibility to adverse effects of low folate in early familial coronary artery disease. Arterioscler Thromb Vasc Biol 1995;15:1314-20.
16. Landgren F, Israelsson B, Lindgren A, et al. Plasma homocysteine in acute myocardial infarction. Homocysteine lowering effect of folic acid. J Int Med 1995;237:381-8.
17. Selhub J, Jacques P, Bostom A, et al. Association between plasma homocysteine concentrations and extracranial carotid artery stenosis. N Engl J Med 1995;332:286-91.
18. Franken D, Boers G, Blom H, et al. Treatment of mild hyperhomocysteinaemia in vascular disease patients. Arterioscler Thromb Vasc Biol 1994;14:465-70.
19. Morrison H, Schaubel D, Desmeules M, et al. Serum folate and risk of fatal coronary heart disease. JAMA 1996;275:1893-6.
20. Cheng SW, Ting AC, Wong J. Fasting total plasma homocysteine and atherosclerotic peripheral vascular disease. Ann Vasc Surg 1997;11:217-23.
21. Den Heijer M, Koster T, Blom HJ, et al. Hyperhomocysteinaemia as a risk factor for deep vein thrombosis. N Engl J Med 1996;334:759-62.
22. Mendis S, Athauda SB, Naser M, et al. Association between hyperhomocysteinaemia and hypertension in Sri Lankans. J Int Med 1999;27:138-44.
23. Wu KK, Thiagarajan P. Role of endothelium in thrombosis and hemostasis. Annu Rev Med 1996;47:315-31.
24. Chen P, Poddar R, Tipa E, et al. Homocysteine metabolism in cardiovascular cells and tissues : Implications for hyperhomocysteinaemia and cardiovascular disease. Adv Enzyme Regul 1999;39:93-109.
25. Stamler JS, Osborne JA, Jaraki O, et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993;91:308-18.
26. Hultberg B, Anderson A, Isaksson A, et al. Metabolism of homocysteine, it's relation to the other cellular thiols and it's mechanism of cell damage in a cell culture line (human histiocytic cell line V-937). Biochim Biophys Acta 1995;1269:6-12.
27. Rolland PH, Friggi A, Barlatier A, et al. Hyperhomocysteinaemia induced vascular damage in the minipig. Captopril hydrochlorothiazide combination prevents elastic alterations. Circulation 1995;91(4):1161-74.
28. Wilcken DE, Reddy SG, Gupta VJ. Homocysteinaemia, ischemic heart disease, and the carrier state for homocystinuria. Metabolism 1983;32:363-70.
29. Ubbink J, Vermaak W, Van der Merwe, et al. Vitamin requirements for the treatment of hyperhomocysteinaemia in humans. J Nutr 1994;124:1927-33.
30. Van den Berg M, Boers G, Franken D, et al. Hyperhomocysteinemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease. Eur J Clin Invest 1995;25:176-81.
31. Wilcken DE, Dudman NP, Tyrell PA, et al. Homocysteinuria due to cystathionine beta-synthase deficiency - the effects of betaine treatment in pyridoxine-responsive patients. Metabolism 1985;12:1115-21.
32. Yeolekar ME. The non-communicable diseases epidemic. Indian J Hypertension 1998;3:41.
33. Maxwell SRJ. Prospects for the use of antioxidant therapies. Drugs 1995;49:345-67.
34. Peterson JC, Spence JD. Vitamins and progression of atherosclerosis in hyperhomocysteinaemia. Lancet 1998;351:263.
35. Brouwer IA, Dusseldrop Chris MG Thomas. Low dose folic acid supplementation decreases plasma homocysteine concentrations : a randomized trial. Am J Clin Nutr 1998;69:99-104.